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Abstract
Background: Nanolipoprotein particles (NLPs) are discoidal, nanometer-sized particles comprised of self-assembled
phospholipid membranes and apolipoproteins. NLPs assembled with human apolipoproteins have been used for myriad
biotechnology applications, including membrane protein solubilization, drug delivery, and diagnostic imaging. To expand
the repertoire of lipoproteins for these applications, insect apolipophorin-III (apoLp-III) was evaluated for the ability to form
discretely-sized, homogeneous, and stable NLPs.
Methodology: Four NLP populations distinct with regards to particle diameters (ranging in size from 10 nm to .25 nm)
and lipid-to-apoLp-III ratios were readily isolated to high purity by size exclusion chromatography. Remodeling of the
purified NLP species over time at 4uC was monitored by native gel electrophoresis, size exclusion chromatography, and
atomic force microscopy. Purified 20 nm NLPs displayed no remodeling and remained stable for over 1 year. Purified NLPs
with 10 nm and 15 nm diameters ultimately remodeled into 20 nm NLPs over a period of months. Intra-particle chemical
cross-linking of apoLp-III stabilized NLPs of all sizes.
Conclusions: ApoLp-III-based NLPs can be readily prepared, purified, characterized, and stabilized, suggesting their utility
for biotechnological applications.
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Introduction
Nanolipoprotein particles (NLPs) are nanometer-sized bilayer
mimetics comprised of phospholipids and apolipoproteins [1,2].
These discoidal particles are also referred to as recombinant high
density lipoproteins (rHDLs) and nanodiscs. NLPs are ideally
suited to solubilize, stabilize, and enable the study of membrane
proteins [3–7], and provide an alternative to traditional mem-
brane protein solubilization approaches including liposomes and
detergent solubilization [8]. Although liposomes, polymeric
particles, and nanoparticles have dominated the field of nanobio-
technology [9–14], NLPs represent a complementary biomimetic
platform for many of the same applications. For example, NLPs
have been used as drug delivery platforms [15–20], for diagnostic
imaging [21,22], and as vaccine platforms for the delivery of
membrane protein [23] and recombinant subunit antigens [24].
NLP size, homogeneity, and stability are important parameters
for biotechnology applications, such as membrane protein
solubilization. In addition, the size of the NLP and the surface
area of the lipid bilayer are key determinants of the potential for
loading of cargo in or on the NLP bilayer. Homogeneity is
important to provide readily characterizable starting material, and
facilitates control over experimental parameters (e.g., stoichiom-
etry). Understanding and characterizing NLP stability over time
provides insight into shelf life of the NLPs, while also providing
preliminary data on NLP integrity during in vitro and in vivo
applications. As such, a clear understanding of both the
methodology required to prepare discretely sized particles, as well
as their inherent stability, is desirable.
The size of NLPs can be tuned in a number of ways. The choice
of starting materials has a great effect, as different combinations of
apolipoproteins and lipids have been demonstrated to generate a
range of NLP sizes. Forexample,the human apolipoprotein apoA-1
hasbeen extensivelystudied,and hasbeendemonstrated toproduce
differently sized NLP species when prepared with either 1,2-
dimyristoyl-sn-glycero-3-phosphocholine (DMPC) or 1-palmitoyl-2-
oleoyl-sn-glycero-3-phosphocholine (POPC) lipids [25]. The iden-
tity of the apolipoprotein is also important, illustrated by the
relatively large diameter NLPs produced with the 22 kDa fragment
of human apoE4 (apoE422K), in contrast to the smaller apoA-I
particles [26]. The ratio of lipid to apolipoprotein is also a major
determinant in the ultimate size of the NLPs, with high ratios
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cholesterol at various molar ratios also affects particle size [28].
The goal of our research is to expand the repertoire of well-
characterized lipoproteins currently available for biotechnological
applications by demonstrating the facile preparation of discretely
sized NLPs using insect apolipophorin III (apoLp-III), and to
characterize their size, composition, and stability. ApoLp-III is
primarily associated with lipid shuttling in hemolymph during
insect flight, although additional roles in membrane remodeling
and innate immunity have been identified [29]. ApoLp-III is a low
molecular weight apolipoprotein (,18 kDa) of high a-helical
content (.70%), similar to vertebrate apolipoproteins. In
particular, apoLp-III has high functional and structural similarity
to the apoE422K [29,30], which has been successfully adapted for
biotechnological applications [3,24,31]. Importantly, and unlike
other apolipoproteins, apoLp-III remains monomeric in the
absence of lipid, even at high concentrations [29].
Herein we describe the successful assembly and purification of
four NLP species of discrete diameter using apoLp-III. The two
apoLp-IIIs chosen for this study were derived from insect species
within the order Lepidoptera: Manduca sexta and Bombyx mori.
These apolipoproteins are unglycosylated, small in size (166 and
164 residues, respectively), readily expressed and purified, share ca.
74% sequence identity [32], and have been well characterized
[33,34]. Four distinct NLP species readily form from apoLp-III
incubated with DMPC and could be isolated to high purity by a
single purification step using size exclusion chromatography. The
NLP species were characterized by size exclusion chromatography
(SEC), non-denaturing gradient gel electrophoresis (NDGGE), and
atomic force microscopy (AFM). The stability of the individual
NLP species assembled with B. mori apoLp-III was monitored for 5
months, which revealed significant remodeling of the smaller NLP
species to a consensus structure with an average diameter of
20 nm. Chemical cross-linking was successful in stabilizing the
individual NLP species for months. Although to date their use in
biotechnological applications has been limited, apoLp-IIIs provide
a means to expand the apolipoprotein toolkit for preparing NLPs
featuring varied size ranges and characteristics.
Materials and Methods
Materials
DMPC was purchased from Avanti Polar Lipids (Alabaster,
AL). All other reagents were ordered from Sigma-Aldrich (St.
Louis, MO).
Protein expression and purification
B. mori and M. sexta apolipophorin III constructs were
generously provided by Dr. Robert Ryan. Proteins were expressed
according to published procedures [33,34]. B. mori apoLp-III
concentrations were determined by UV spectroscopy at 280 nm in
3 M guanidine hydrochloride (e280=6970 M
21 cm
21). M. sexta
apoLp-III concentrations were determined with the Advanced
Protein Assay Reagent (Cytoskeleton Inc., Denver, CO), using
BSA as a standard.
NLP assembly
NLPs were assembled according to previously reported proce-
dures [2,31,35] with slight modifications. Briefly, lipids in
chloroform were aliquoted into glass vials. Chloroform was then
removed using a stream of N2 under agitation to form a thin lipid
film,whichwasfurtherdriedinvacuoforatleast2 hours.Lipidswere
then solubilized in TBS buffer (10 mM Tris, 150 mM NaCl,
pH 7.4) with 20 mM sodium cholate. After addition of apoLp-III,
samples were incubated at 23.8uC for at least 4 hours. Final apoLp-
III concentrations were ca. 150 mM during a typical assembly.
Assemblies were then dialyzed against TBS to remove cholate and
promoteNLPself-assembly.Assembliesweresubsequentlyanalyzed
and purified by SEC (Superdex 200, 10/300 GL column, GE
Healthcare, Piscataway, NJ) in TBS buffer (0.5 mL/min flow rate,
l=280 nm). Prior to SEC analysis, all samples were filtered using a
0.22 mm spin filter (Agilent) to remove any particulates. NLP
fractions were analyzed by NDGGE and/or AFM. For NDGGE,
4–20% Tris-glycine polyacrylamide gels were used (Invitrogen,
Carlsbad, CA). For all native gels, the NativeMark protein standard
was used (Invitrogen). All gels were stained with SyproRuby
(BioRad, Hercules, CA) and imaged using the Typhoon 9410
Variable Mode Imager (GE Healthcare). For remodeling studies,
four large assemblies were prepared (175:1, 135:1, 75:1, and 45:1
lipid:apoLp-III molar ratios) to enrich the four different NLP
populations (NLP-1, NLP-2, NLP-3 and NLP-4, respectively). To
isolate the four different NLP populations, appropriate SEC
fractions were pooled (Figure S1A). These fractions were stored
at 4uC and, at indicated time points, a portion of each was analyzed
by SEC, NDGGE, and/or AFM. For SEC chromatogram
quantitation, a Nonlinear Least Squares Fitter (Origin 7, OriginLab
Corp, Northampton, MA) was used to fit a multi-peak Gaussian
function, corresponding to the appropriate NLP, lipid, or protein
components. The integrated peak area was then used to assess
relative abundance of each population.
NLP composition analysis
Protein and lipid compositions were assessed for each purified NLP
population. B. mori apoLp-III concentrations were determined by UV
spectroscopy at 280 nm in 3 M guanidinium hydrochloride
(e280=6970M
21 cm
21). DMPC concentrations were assessed using
the colorimetric Phospholipids C kit purchased from Wako Chemicals
USA, Inc. (Richmond, VA), following manufacturer’s protocol using
choline as a standard. For calculations of lipid bilayer area based on
AFM-determined NLP diameters and DMPC molecular area,
apolipophorin helices were assumed to contribute 2 nm to the overall
diameter of the NLPs [36,37]. To calculate lipid molecules per NLP, a
published value of 0.6 nm
2 per DMPC was used [38,39] (DMPC/
NLP=p(rNLP-1)
2/0.6). After 162 days, the 20 nm NLPs in NLP-4
were purified by SEC for composition analysis.
NLP cross-linking
For cross-linking experiments, NLP populations isolated by
SEC were incubated with Bis-N-succinimidyl-(pentaethylene
glycol) ester (henceforth abbreviated as PEO5). NLPs (ca.2 5n g
apoLp-III per mL) in HEPES buffer (10 mM HEPES, 75 mM
NaCl, pH 7.4) were incubated with 0, 0.5 and 5 mM PEO5 for
four hours at room temperature. Reactions were quenched with
50 mM Tris-HCl (pH 7.4) for 30 minutes at room temperature.
Samples were analyzed by NDGGE (4–20% Tris-glycine) and
SDS PAGE (4–12% Bis-Tris with MES running buffer or 3–8%
Tris-acetate with tricine running buffer). For denaturing gels, the
Mark12 protein standard was used (Invitrogen).
AFM analysis of NLPs
AFM measurements and analyses were conducted as previously
described [31,35,36].
Results
NLP formation using B. mori and M. sexta apoLp-III
Discoidal nanolipoprotein particles have been prepared using
purified apoLp-III from myriad species, including Locusta migratoria,
NLPs Assembled with apoLp-III
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apolipophorin-based NLPs for biotechnology applications, NLPs
assembled using apoLp-III from B. mori and M. sexta were
investigated. Various lipid:apoLp-III ratios were surveyed for
successful NLP formation. ApoLp-III was incubated with DMPC
in the presence of cholate for ca. 4 hours at 23.8uC. After dialysis
of the assembly reactions to remove excess cholate, samples were
analyzed by SEC. The resultant chromatograms were effectively
parsed into 6 distinct regions (Figure 1), corresponding to lipid-
rich complexes (Region 1, ,16 min), four distinct NLP peaks
(Regions 2 to 5, ,18 to 28 min), and protein-rich species (Region
6, ,33 min). Identical peaks were observed in assemblies
containing B. mori and M. sexta apoLp-III. Assemblies at high
lipid:protein ratios were predominated by large, lipid-rich
complexes eluting in the column void volume (,16 min) and
two NLP species (,18 and ,21 min). Smaller NLP species were
observed (,23.5 and 27 min) at lower lipid ratios. As the
lipid:protein ratios were decreased, the amount of unincorporated
protein increased (,33 min), suggesting that not enough lipid was
present to utilize all the protein for NLP formation. These results
resemble the well-established phenomenon that NLP size can be
controlled by lipid:apolipoprotein stoichiometry [25,27]. While
apoLp-III derived from both M. sexta and B. mori successfully
formed NLPs, the latter was chosen for further in-depth analysis.
The primary reason for this was the difficulty in the detection and
quantitation of M. sexta-derived NLPs; the protein has only a single
tyrosine residue (and no tryptophan) and hence low intrinsic
absorbance.
Identification of discrete NLP species
To verify that the particles isolated from the SEC regions 2 to 5
were indeed NLPs, two independent techniques were used to
characterize the B. mori assemblies; NDGGE and AFM. NDGGE
is a traditional analytical technique used to differentiate between
NLPs of varying sizes according to electrophoretic mobility and
apparent molecular weight. AFM provides single-particle analysis
of NLP diameter and height.
First, four assembly conditions (i.e., molar lipid:protein ratios)
were identified from Figure 1 that enriched a particular NLP
species. The lipid:apoLp-III molar ratios used to form NLP species
of different sizes were 175:1, 135:1, 75:1 and 45:1 (Figure S1).
The 175:1 ratio produced large NLPs with a retention time of ,18
minutes, henceforth referred to as NLP-1. NLP-2 denotes the
species with a retention time of ,21 minutes, and was the
dominant species produced using a 135:1 molar ratio. Molar ratios
of 75:1 and 45:1 produced enriched NLP species at ,23 and ,27
minutes, respectively, termed NLP-3 and NLP-4. The fractions
corresponding to the desired NLP species were pooled and
reanalyzed by SEC (Figure 2A) to demonstrate purity. All
subsequent characterization was conducted on these purified
NLPs (NLP-1, NLP-2, NLP-3, NLP-4). NDGGE demonstrated
that each SEC peak corresponded to a discrete NLP species,
except NLP-1 (Figure 2B). NLP-1 was characterized by two
dominant and multiple faint bands, suggesting multiple NLP
species ranging in apparent molecular weight (MW) from ,950 to
1100 kDa (Table 1). This was not unexpected, as the SEC
column used in these studies had limited resolution for particles
with apparent MW in this range. The remaining three NLP
species were dominated by species at ca. 560, 360, and 220 kDa
(NLP-2, NLP-3, and NLP-4, respectively). To further verify the
presence of NLPs, AFM was used to confirm the discoidal
morphology of the purified species (Figure S2). Single particle
analysis by AFM elucidated that NLP-1 was comprised of
numerous different sized NLP species (Figure 2C), corroborating
the presence of multiple bands by NDGGE. The two dominant
species were 25.460.9 nm and 30.561.1 nm in diameter; two
minor species were 20.061.6 and 35.161.3 nm. The other three
NLP species were each characterized by a single dominant species
with average diameters of 20 nm, 15 nm, and 10 nm (NLP-2,
NLP-3, and NLP-4, respectively) (Figure 2C and Table 1). The
Figure 1. SEC chromatograms of NLP assemblies at various
lipid-to-apoLp-III molar ratios. NLPs were assembled with DMPC
and apoLp-III from A) Bombyx mori or B) Manduca sexta. SEC traces are
parsed into 6 distinct regions: 1, lipid-rich; 2–5, NLPs; 6, protein-rich.
Exclusion limit of the column (Vo) and molecular weights of protein
standards are indicated.
doi:10.1371/journal.pone.0011643.g001
Figure 2. Characterization of purified B. mori apoLp-III NLP
species. A) SEC analysis of purified NLPs. B) NDGGE analysis of purified
NLPs. C) AFM size distributions for each population are shown (n.120,
1.5 nm binning intervals). Representative AFM images are shown in
Figure S2.
doi:10.1371/journal.pone.0011643.g002
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PLoS ONE | www.plosone.org 3 July 2010 | Volume 5 | Issue 7 | e11643heights of the three largest purified NLP species (NLP-1, NLP-2,
and NLP-3) were ca. 6.2 nm, whereas the smallest NLP-4 species
was 5.2 nm.
Compositional analysis of NLP species
The four purified NLP species were analyzed to determine the
lipid-to-apolipophorin ratios as well as the number of apolipophorin
molecules per NLP. The composition of each NLP species was
elucidated by independently determining the lipid and protein
concentrations of purified NLPs, providing molar ratios of the NLP
constituents (see experimental section for details). As summarized in
Table 1, the lipid:protein ratio increased as the size of the NLPs
increased. The number of apoLp-III molecules in each of the four
NLP species was elucidated by chemically cross-linking available
free amines on the apoLp-III surface using the symmetric cross-
linker PEO5. To avoid inter-NLP cross-linking, dilute NLP
concentrations were used for these studies. By NDGGE
(Figure 3A), cross-linked NLPs remained intact and exhibited
slightly faster mobility, presumably due to modification of the NLP
surface charge due to cross-linking through solvent-exposed lysine
residues. Importantly, no higher molecular weight bands were
observed in the cross-linked species, indicating that inter-particle
cross-linking did not take place or had undetectable occurrence.
When analyzed on denaturing gels, different dominant bands
corresponding to cross-linked apoLp-III were observed for each
NLP species (Figure 3B). Higher molecular weight bands were
observed as the size of the NLP increased. For example, cross-linked
NLP-1 displayed intense bands corresponding to five, six and seven
cross-linked apoLp-III molecules. NLP-2, 3, and 4 displayed bands
that correlated to primarily four, three, and two cross-linked apoLp-
III molecules, respectively (Table 1). No difference in cross-linking
efficiency was observed between 0.5 and 5 mM PEO5, suggesting
that the cross-linkingreactionwascomplete.Toelucidate thehigher
molecular weight species corresponding to multiple cross-linked
apoLp-III molecules, samples were separated on a 3–8% Tris-
acetate gel (Figure S3) and the results correlated well with those
shown in Figure 3B. Based on the number of apolipophorin
molecules in each NLP and the lipid:protein ratio determined by
lipid and protein quantification, the total number of lipid molecules
contained within the NLP bilayers were calculated to be 6366105,
447635, 190640, and 107615 for NLP-1, NLP-2, NLP-3, and
NLP-4, respectively (Table 1). Independent estimates of the
number of lipid molecules per NLP based on particle diameter
and molecular area of the DMPC lipid headgroups were within the
margin of error determined by compositional analysis. Assuming an
average DMPC molecular area of 0.6 nm
2 [38,39], and an apoLp-
III helical thickness of 1 nm [37], the average number of DMPC
molecules per NLP extrapolated from the NLP diameter as
measured by AFM were 717655, 424675, 217627, and
99625 nm for NLP-1, NLP-2, NLP-3, and NLP-4, respectively
(Table 1).
Dynamic remodeling of NLP species
NLPs were monitored at various time points during storage and
stability was assessed by both bulk and single molecule analyses.
Table 1. Summary of NLP characteristics.
NLP-1 NLP-2 NLP-3 NLP-4
AFM diameter (nm)
a $25
g 20.061.6 14.960.8 10.761.1
AFM height (nm) 6.160.3 6.360.4 6.160.5 5.260.5
Apparent MW (kDa) by SEC 1015 556 263 116
Apparent MW (kDa) by
NDGGE
930, 1040 561 365 217
Input DMPC/apoLpIII
b 175 135 75 45
# DMPC/apoLpIII
c 127.2620.9





e 6366105 447635 190640 107615
DMPC/NLP
f 717655 424675 217627 99625
aCalculated from full-width half-maximum (FWHM).
bMolar lipid-to-protein ratio.
cDMPC quantified using enzymatic assay. ApoLp-III quantified by UV-Vis
spectroscopy.
dNumber of apoLp-III molecules determined by chemical cross-linking and SDS
gel visualization.
eCalculated using experimentally determined DMPC/apoLp-III and apoLp-III/
NLP.
fCalculated based on measured AFM diameters and DMPC molecular area,
assuming 0.6 nm
2/DMPC and 1 nm apoLp-III helix thickness. DMPC/
NLP=p(rNLP-1)
2/0.6.
gNLP-1 comprised of three main species: 25.460.9 nm, 30.561.1 nm, and
35.161.3 nm.
hNumber of DMPC lipid molecules per NLP was determined for aggregate of all
NLP-1 sizes.
i25 nm, 30 nm, and 35 nm NLP-1 species hypothesized to contain 5, 6 and 7
apoLp-III molecules, respectively.
doi:10.1371/journal.pone.0011643.t001 Figure 3. Gel analysis of cross-linking experiments. Purified B.
mori apoLp-III NLP species were cross-linked with indicated concentra-
tions of PEO5 and analyzed by gel electrophoresis. A) NDGGE (4–20%
Tris-glycine) demonstrates that NLPs maintain integrity upon cross-
linking. B) Denaturing SDS PAGE (4–12% Bis-tris gel) bands correlate to
number of apolipoprotein molecules. To verify mobility of high
molecular weight bands, a 3–8% Tris-acetate SDS gel was run (see
Figure S3).
doi:10.1371/journal.pone.0011643.g003
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periodically assessed over 5 months. SEC and NDGGE were used
to measure changes in the average characteristics of the bulk
sample, whereas AFM was used for single particle measurements.
Each purified NLP species was assessed by SEC at periodic
intervals to determine the purity of the samples. If remodeling
occurred, a decline in the overall percentage of the originally
isolated and purified NLP would be observed, along with a
concomitant increase in the amount of NLPs of other sizes. The
SEC chromatograms were analyzed to assess relative abundance
of each NLP species, as well as the lipid- and protein-rich
components (Figure 4). Nonlinear least squares fitter (Origin 7,
OriginLab Corp.) was used to fit the multiple peaks of the
chromatograms to Gaussian functions, facilitating the integration
of the six chromatogram regions. NLP-1 demonstrated little
change in overall abundance of the main peak centered at 18 min
(Figure 4A,E). Similarly, NLP-2 remained unchanged over the 5
month period (Figure 4B,F). In contrast, a dramatic remodeling
of the originally isolated NLP species was seen in the smaller NLP-
3 and NLP-4 species. In the case of NLP-3, a rapid disassembly of
the NLP-3 particles occurred, which was mirrored by concomitant
increases in both NLP-2 particles and free protein (Figure 4C,G).
By 50 days, NLP-2 was the dominant NLP species and remained
so for the duration of the study. Similarly, the NLP-4 population
underwent significant remodeling (Figure 4D,H). Within 30
days, over 50% of the NLP-4 particles had disassembled, and an
increase in both NLP-2 and NLP-3 species was observed. Again, a
rise in free Lp-III was observed. By the end of the study, the
sample was comprised of similar percentages of the NLP-2 and
NLP-3 particles. Identical results were observed by NDGGE (see
Figure S4).
To determine if NLPs of a particular size formed by remodeling
were identical to those initially purified from an assembly, NLP-2
species remodeled from NLP-4 (after 162 days) were isolated by
SEC. The purified NLP-2 population was then analyzed for
DMPC and apoLp-III content. The composition of NLP-2 formed
through remodeling of the NLP-4 species was identical to the
stable NLP-2 particles originally purified from the NLP assembly
(110.9618.7 DMPC/apoLp-III vs. 111.668.7 nm DMPC/
apoLp-III, respectively).
Single particle measurements using AFM gave results that were
consistent with bulk measurements. AFM was used to measure
NLP diameters, which allowed us to assess the distribution of NLP
species. As free protein and lipid were not readily measurable by
AFM, a direct comparison between AFM and SEC was afforded
by looking at the distribution of NLP species as a fraction of total
NLPs. For representation of AFM data, NLPs were assigned
according to diameter (NLP-1, $25 nm; NLP-2, 20 nm; NLP-3,
15 nm; NLP-4, 10 nm). The relative abundance of each NLP
species at each time point was nearly identical between AFM and
SEC (Figure 5 and Figure S5).
The single particle measurements by AFM elucidated popula-
tion distributions in NLP-1 that were undetected by SEC (due to
resolution limitations of the SEC column used in this study)
(Figure S6). By SEC, all NLP-1 chromatograms featured a
dominant peak at 18.2 minutes, suggesting no change in NLP-1
size. However, the ability to interrogate individual NLPs by AFM
provided greater resolution to measure larger particles. On Day 0,
the 25 nm NLPs were the dominant species, followed closely by
30 nm and 35 nm NLPs. By Day 25, 30 nm NLPs were the
majority species, although significant amounts of the other NLP
species were still present. After 150 days, however, the only true
Figure 4. SEC analysis of NLP remodeling. Purified B. mori apoLp-III NLPs were stored at 4uC and monitored over 5 months by SEC. A–D) Raw
SEC chromatograms were quantified by multi-peak integration of SEC chromatograms. E–H) Relative abundance of individual components
corresponding to NLP peaks (NLP-1, NLP-2, NLP-3, NLP-4) or non-NLP peaks (lipid- or protein-rich species) is represented as percent of total
chromatogram signal integration. A,E) NLP-1, B,F) NLP-2, C,G) NLP-3, and D,H) NLP-4. Nomenclature of remodeled NLPs was assigned according to
retention time (NLP-1, Region 2, 18 min; NLP-2, Region 3, 21 min; NLP-3, Region 4, 23.5 min; NLP-4, Region 5, 27 min). Lipid- and protein-rich peaks
had retention times of 16 (Region 1) and 33 min (Region 6), respectively.
doi:10.1371/journal.pone.0011643.g004
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present in significant quantities were the 30 nm particles.
Although NLPs larger than 37.5 nm could be present, AFM is
not able to distinguish these larger NLPs from these from adhered
liposomes [42,43].
Stability of cross-linked NLP species
The dynamic remodeling, or instability, of NLPs can present
difficulties for applications requiring stable NLPs of discrete sizes.
To address this, we investigated the possibility of increasing the
stability of NLPs by chemically cross-linking free reactive amines
available on the apoLp-III protein surface. While cross-linking of
lipoprotein constituents has been done for decades to identify the
number of lipoprotein molecules per particle, to our knowledge
the subsequent stability of these particles has never been studied.
Cross-linked and non-cross-linked NLPs were stored at 4uC and
analyzed after two months by NDGGE (Figure 6). Again, the
cross-linked NLPs exhibited slightly greater mobility than the non-
cross-linked NLPs, presumably due to modification of the NLP
surface charge due to cross-linking through solvent-exposed lysine
residues. As anticipated, the non-cross-linked NLP-1 and NLP-2
species were still present, whereas NLP-3 and NLP-4 were no
longer present. Conversely, the cross-linked NLP species exhibited
discrete bands that were identical to the starting samples (compare
Figure 6 to Figure 3), indicating that particle size persisted.
These data suggest that the NLPs can be stabilized through
chemical cross-linking. Significant stability of cross-linked NLP
was also observed after one year of storage, although some
degradation was evident (data not shown). These results
demonstrate that chemical cross-linking provided a means to
stabilize the 10 and 15 nm NLP species. The non-cross-linked
20 nm NLP-2, on the other hand, was completely stable after one
year of storage, indicating that further stabilization of that species
by cross-linking was not necessary.
Discussion
The versatile nature of the NLP assembly process readily
accommodates a diverse range in both the lipid [26,31,44,45] and
protein [26,29,46] constituents. Importantly, the choice of starting
material and assembly conditions provides the ability to control the
purity,size,andstabilityoftheNLPs.ThemajorityofNLPsused for
biotechnology applications have utilized human apolipoproteins, in
particular apoA-1 [15,22,45] and apoE4 [3,24,31]. As the identity
of apolipoprotein has an impact on NLP size and stability,
characterizing NLPs formed with additional apolipoproteins
expands the repertoire of NLP building blocks. To this end, insect
apolipophorins represent excellent candidates as they can be readily
expressed and purified, and are well characterized [33,40,41].
NLPs have been identified as platforms for many biotechno-
logical applications, including therapeutics and diagnostics
[15–22,24,31]. Furthermore, the use of NLPs for membrane
protein solubilization and stabilization has greatly expanded in
recent years [3–7,47]. This technology has now been optimized for
broad applicability, as epitomized by Invitrogen’s Membrane-
Max
TM commercially available protein expression kit based on in
vitro protein translation. Specifically for membrane protein
solubilization, NLP size homogeneity is an important factor for
a variety of applications. In particular, structural characterization
of membrane proteins is greatly facilitated by homogeneous NLP
populations as well as control over the number of membrane
proteins incorporated into the NLP bilayer. A means of
systematically controlling both size and stability of the NLPs, as
described herein, would be of great benefit to this technology.
Characterization of discretely sized NLP species
NLPs were successfully prepared using apolipophorin III from
two insect species, B. mori and M. sexta. Varying the lipid to
apoLp-III ratios resulted in the formation of four distinct NLP
sizes elucidated by SEC. These distinct NLP populations could be
readily isolated to a high degree of purity by a single SEC
purification step. In contrast, purification of apoA-I-derived NLPs
is not easily achieved by SEC, and requires a more laborious
approach using ultracentrifugation [25,27]. Using NDGGE and
AFM, the presence of four distinct NLP species were identified
(Table 1). NLP-1, while appearing as a single species by SEC,
was more adequately resolved by NDGGE and AFM. By
NDGGE, NLP-1 was a high molecular weight smear, represented
by three to four faint bands. AFM was able to resolve the
presence of three uniquely sized NLP species with diameters of ca.
25, 30 and 35 nm. Although objects of large diameter were
Figure 5. Comparative assessment of B. mori apoLp-III NLP
remodeling by AFM and SEC. Identical trends in the fate of the four
purified NLP species stored over 5 months at 4uC are elucidated by both
single molecule (AFM) and bulk (SEC) measurements. A) NLP-1, B) NLP-
2, C) NLP-3, and D) NLP-4. For representation of AFM data,
nomenclature of remodeled NLPs was assigned according to diameter
(NLP-1, $25 nm; NLP-2, 20 nm; NLP-3, 15 nm; NLP-4, 10 nm).
doi:10.1371/journal.pone.0011643.g005
Figure 6. Stability analysis of cross-linked B. mori apoLp-III
NLPs stored for two months at 4uC. Cross-linked and non-cross-
linked samples (0.5 mM PEO5) were analyzed by NDGGE. Stable cross-
linked species are indicated by arrowheads.
doi:10.1371/journal.pone.0011643.g006
NLPs Assembled with apoLp-III
PLoS ONE | www.plosone.org 6 July 2010 | Volume 5 | Issue 7 | e11643observed, AFM was not able to distinguish these from adhered
liposomes, which can be as small as 40 nm in diameter [42,43].
Interestingly, the height of the small NLP-4 species is almost
1 nm shorter than all other B. mori NLPs (Table 1). This may
suggest that lipid packing or overall structure of the small NLPs
may be quite different than the larger NLPs. A number of studies
have reported that NLPs of smaller diameters may not assume a
discoidal morphology characterized by a planar bilayer [48].
Rather, these particles assume a saddle-shaped structure
exhibiting a minimal surface [49,50]. Alternatively, the interac-
tion forces between the mica surface and particle may be different
when the NLPs are this small, potentially affecting the thickness
of the intervening water layer. Addressing this discrepancy merits
further investigation.
NLP remodeling
A number of groups have investigated the spontaneous
remodeling of apoA-I-based rHDLs over time [25,51–53] as well
as resulting from actions by enzymes such as phospholipid transfer
protein [54], lecithin:cholesterol acyltransferase [55], and choles-
teryl ester transfer protein [56]. Although anticipated based on the
observations made with apoA-I, no evidence of the remodeling of
apoLp-III based particles has been reported.
As the stability of discretely sized NLP species is important for
most potential applications, we examined the stability of apoLp-III
NLPs of different sizes over time. In contrast to SEC, AFM
demonstrated that remodeling of NLP-1 indeed occurred,
resulting in a predominance of 30 nm particles by the end of
the test period. An increase in particles greater than 37.5 nm in
diameter may suggest that a mechanism for producing the most
stable 30 nm species involves the formation and dissociation of
much larger structures. The inability of the AFM to adequately
resolve these very large structures as NLPs, however, limits the
ability to draw firm conclusions from these data. NLP-2 displays
no remodeling over the entire test period at 4uC, indicating that
the 20 nm NLPs comprised of 4 Lp-III molecules were very stable.
Indeed, NLP-2 samples stored for 13 months were completely
homogeneous and exhibited no remodeling by NDGGE (data not
shown). The stability of NLP-2 species was also demonstrated by
the time-dependent remodeling of the smaller NLP species, NLP-3
and NLP-4. NLP-3 exhibited minimal stability over time,
remodeling to form predominantly the 20 nm NLP-2, accompa-
nied by the appearance of free apoLp-III. Remodeling of the NLP-
3 may involve NLP-4 as an intermediate, as evidenced by the
appearance of a significant fraction of NLP-4 by 50 days. NLP-4
also demonstrated rapid remodeling, resulting in predominantly
NLP-2 and free apoLp-III. NLP-3 may play a role as an
intermediate during the remodeling process, peaking at ,20%
by 29 days. These data suggest that NLP-2 species are the most
stable, and that smaller NLPs will ultimately rearrange to form
NLP-2. This is corroborated by the compositional analysis of the
20 nm particle (NLP-2) formed by remodeling, indicating nearly
identical molar DMPC to apoLp-III ratios as NLP-2 particles
directly purified from an assembly reaction. When experiments
were conducted at 25uC, similar remodeling profiles were
observed (data not shown). NLP-3 and NLP-4 remodeled to form
predominantly the 20 nm NLP-2, although the remodeling time
scales were accelerated 5-fold. The stability of NLP-2 decreased as
well, and exhibited a half-life of approximately 15 days (data not
shown).
The remodeling data suggest that total lipid in the system is the
limiting factor for the remodeling of the NLP-3 and NLP-4
species. Free apoLp-III accumulated as more of the smaller NLPs
remodeled into NLP-2, while no free lipid was observed. The
remodeling of the smaller NLP species follows a complex
mechanism, involving the disassembly and reassembly of the
three different NLP species (i.e., NLP-2, -3, and -4), ultimately
resulting in a preponderance of the 20 nm NLP-2. As demon-
strated in Figure 4, the path from NLP-3 to NLP-2 involved an
NLP-4 intermediary. Similarly, NLP-3 was transiently formed as
NLP-4 remodeled to NLP-2. As outlined in Figure 7, the
intermediate NLPs are a proposed consequence of the disassembly
of the initial kinetic products to ultimately form the thermody-
namically stable NLP-2 species. In all cases, lipid appears to be the
limiting reagent. In the proposed remodeling scheme (and
supported by experimental evidence), NLP disassembly results in
free apoLp-III. This is anticipated, as the smaller NLP species
have much lower lipid-to-apoLp-III ratios (53:1 and 63:1, for
NLP-4 and NLP-3, respectively) than NLP-2 (ca. 110:1) (Table 1).
To illustrate this, the remodeling schemes of NLP-3 and NLP-4
are depicted in Figure 7. The 15 nm NLP-3 species represents a
kinetic minimum when DMPC and apoLp-III are initially
assembled at a 75:1 ratio. Over time, however, a more
thermodynamically stable structure is produced (NLP-2), accom-
panied by a small fraction of transient NLP-4 species. For
example, 3 NLP-3 particles are needed to satisfy the total lipid
amount needed for one NLP-2 particle (450 DMPC molecules).
The remaining 5 free apoLp-III molecules and ca. 120 lipid
molecules can then reassemble into a single NLP-4 species
(comprised of 2 apoLp-III and ca. 105 DMPC molecules). These
intermediate NLP-4 particles will ultimately remodel to form the
NLP-2 species. A similar mechanism can be described for NLP-4
(Figure 7). The disparity between kinetic and thermodynamic
NLP products may be attributed to elasticity of apolipoprotein
conformations. For example, human apoAI has been shown to
assume myriad conformations, contributing to an overall broad
conformational space [57,58] that is dependent on temperature
and constituent ratios. These results are consistent with the
observed stability of cross-linked NLPs, whereby the conforma-
tional space of the apoLp-III is greatly limited due to the covalent
inter-apoLp-III cross-linking within each NLP.
Bulk vs. single molecule measurements
The combination of bulk and single-molecule analyses is a
powerful tool for the study of NLPs. The strong correlation
between the AFM and SEC monitoring of NLP remodeling is
important (Figure 5 and Figure S5), as it validates the utility of
both techniques in the study of NLPs. Furthermore, the tandem
use of these techniques provides additional information beyond
use of a single technique. The analysis of bulk characteristics using
SEC provides insight into the average behavior. Importantly, SEC
provided information of the presence of both lipid-rich and
protein-rich species. This compensated for a limitation of AFM,
namely the inability to easily interrogate single proteins on the
mica surface. Conversely, AFM provided data on larger NLPs that
were beyond the resolving capability of the SEC column used in
this study. Had SEC alone been used to monitor the NLP-1
species, the remodeling of larger NLPs to 30 nm particles would
not have been elucidated.
Conclusion
In conclusion, we have demonstrated the ability to tailor the size
of lipophorin-based NLPs. Four discrete NLP species with
diameters of 10 nm, 15 nm, 20 nm, and $25 nm can be readily
assembled, purified to homogeneity by SEC, and characterized.
Bulk and single-particle analyses demonstrated that the 15 nm and
10 nm NLP species undergo spontaneous remodeling over time.
However, the 20 nm NLP were extremely stable, and demon-
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While smaller NLPs had only limited stability, chemical cross-
linking can extend NLP stability to many months. These finding
provide a knowledge base for the rational design of lipophorin
NLPs for biotechnology applications.
Supporting Information
Figure S1 Isolation of B. mori apoLp-III NLP species. A) To
isolate the various NLP peaks observed by SEC, four lipid:protein
ratios were chosen to provide significant enrichment of the
individual peaks (NLP-1, 175:1; NLP-2, 135:1; NLP-3, 75:1; NLP-
4, 45:1). SEC fractions (shaded regions) for each NLP peak were
pooled for further analysis. B) Pooled fractions from (A) were
reanalyzed by SEC, demonstrating purity of the NLP species.
Found at: doi:10.1371/journal.pone.0011643.s001 (0.20 MB TIF)
Figure S2 Representative AFM micrographs of the four B. mori
apoLp-III NLP species purified by SEC. Scale bars correspond to
50 nm. Full-width half-maximum analysis of NLP diameter is
represented by the green area in the pseudo-colored image, which
accounts for the tip convolution effect. The slow scan direction
(vertical) was used for particle diameter analysis.
Found at: doi:10.1371/journal.pone.0011643.s002 (1.11 MB TIF)
Figure S3 Gel analysis of crosslinking experiments. SDS-PAGE
(3–8% Tris-acetate, MES running buffer) was used to resolve high
molecular weight bands upon crosslinking of purified B. mori
apoLp-III NLP species.
Found at: doi:10.1371/journal.pone.0011643.s003 (0.39 MB TIF)
Figure S4 NDGGE of NLP species monitored over time. NLPs
incubated at 4uC were analyzed to demonstrate remodeling of
individual NLP species. A) Day 1, B) Day 29, C) Day 49, D) Day
70, E) Day 97, F) Day 162.
Found at: doi:10.1371/journal.pone.0011643.s004 (0.45 MB TIF)
Figure S5 Direct comparison of NLP remodeling assessment by
single molecule analysis (AFM) and bulk analysis (SEC). A–D)
Single particle AFM analysis of the distribution of the four purified
NLP species. A) NLP-1, B) NLP-2, C) NLP-3, and D) NLP-4. E–
H). Bulk SEC analysis derived by integration of the four individual
NLP SEC peaks. E) NLP-1, F) NLP-2, G) NLP-3, and H) NLP-4.
Only the distribution of NLP species are included in the SEC
analysis, not lipid- or protein rich species.
Found at: doi:10.1371/journal.pone.0011643.s005 (0.43 MB TIF)
Figure S6 AFM identifies four unique NLP sizes in purified
NLP-1 population. Single particle AFM analysis of NLP-1
identifies four unique NLP sizes not elucidated by SEC.
Found at: doi:10.1371/journal.pone.0011643.s006 (0.11 MB
TIF)
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